Coronavirus vaccine developer CureVac shares surge in U.S. debutnewswriter (-2)(1)in #news • 4 years ago FILE PHOTO: Employee Philipp Hoffmann, of German biopharmaceutical company Cure Vac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen (Image not shown due to low ratings)Images were hidden due to low ratings.Show #world #investing